A pilot, open study to assess efficacy and safety of ON-01910 (rigosertib) in patients with recessive dystrophic epidermolysis bullosa associated locally advanced/metastatic squamous cell carcinoma

被引：0

作者：

Banner, Lauren

Hosler, Linda

Parris, Matthew

Gelder, Mark Stephen

Laimer, Martin

Bauer, Johann

South, Andrew

Nikbakht, Neda

机构：

[1] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA

[2] Jefferson Clin Res Inst, Philadelphia, PA USA

[3] Onconova Therapeut, Newtown, PA USA

[4] Onconova Therapeut Inc, Montgomery, TX USA

[5] Paracelsus Med Univ Salzburg, Dept Dermatol & Allergol, Salzburg, Austria

[6] Dept Dermatol & Cutaneous Biol, Philadelphia, PA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS9604

引用

页数：1